Search Results - "Burge, Matthew E"

The Therapeutic Landscape for KRAS -Mutated Colorectal Cancers.

Authors: Tria, Simon Manuel Burge, Matthew E. Whitehall, Vicki L. J.

Source: Cancers. Apr2023, Vol. 15 Issue 8, p2375. 25p.

A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers.

Authors: Burge, Matthew E. O'Rourke, Nick Cavallucci, David et al.

Source: HPB (1365-182X). Jul2015, Vol. 17 Issue 7, p624-631. 8p.

Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial.

Authors: Courneya, Kerry S. Vardy, Janette L. O'Callaghan, Christopher J. et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. Jun2016, Vol. 25 Issue 6, p969-977.

Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland.

Authors: Chapman, Suzannah J McKavanagh, Daniel Burge, Matthew E et al.

Source: Asia Pacific Journal of Clinical Oncology. Oct2017, Vol. 13 Issue 5, pe253-e261. 9p.

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.

Authors: Courneya, Kerry S. Vardy, Janette L. O'Callaghan, Christopher J. et al.

Source: New England Journal of Medicine. 7/3/2025, Vol. 393 Issue 1, p13-25. 13p.

[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial.

Authors: Chan, David L. Sjoquist, Katrin Marie Ransom, David Turner et al.

Source: European Journal of Cancer. Jun2026, Vol. 241, pN.PAG-N.PAG. 1p.

PET imaging quantifying ⁶⁸Ga-PSMA-11 uptake in metastatic colorectal cancer.

Authors: Cuda, Tahleesa J. Riddell, Andrew D. Cheng Liu et al.

Source: Journal of Nuclear Medicine. Dec2020, Vol. 61 Issue 12, p1-28. 28p.

PET imaging quantifying 68Ga-PSMA-11 uptake in metastatic colorectal cancer.

Authors: Cuda, Tahleesa J. Riddell, Andrew D. Liu, Cheng et al.

Source: Journal of Nuclear Medicine. May2020, Vol. 61 Issue 5, p1-28. 28p. 2 Color Photographs, 8 Charts, 3 Graphs.

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

Authors: Chan KKW Chu RWK Cheung MC et al.

Corporate Authors: Chan KKW Chu RWK Cheung MC et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Aug; Vol. 44 (22), pp. 2130-2139. Date of Electronic Publication: 2026 May 31.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG).

Authors: Burge ME Espinoza D Sjoquist KM et al.

Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2025 Jun; Vol. 24 (2), pp. 120-128. Date of Electronic Publication: 2024 Dec 12.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial.

Authors: Tie J Wang Y Lo SN et al.

Source: Nature medicine [Nat Med] 2025 May; Vol. 31 (5), pp. 1509-1518. Date of Electronic Publication: 2025 Mar 07.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol.

Authors: White C Wardill H Paul C et al.

Source: BMC cancer [BMC Cancer] 2024 Nov 08; Vol. 24 (1), pp. 1369. Date of Electronic Publication: 2024 Nov 08.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.

Authors: Tie J Cohen JD Lo SN et al.

Source: International journal of cancer [Int J Cancer] 2021 Feb 15; Vol. 148 (4), pp. 1014-1026. Date of Electronic Publication: 2020 Oct 06.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Authors: Fennell LJ Clendenning M McKeone DM et al.

Source: Familial cancer [Fam Cancer] 2018 Jan; Vol. 17 (1), pp. 63-69.

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer.

Authors: Hill AG Findlay MP Burge ME et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 May 15; Vol. 24 (10), pp. 2276-2284. Date of Electronic Publication: 2018 Mar 05.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Copy number profiles of paired primary and metastatic colorectal cancers.

Authors: Kawamata F Patch AM Nones K et al.

Source: Oncotarget [Oncotarget] 2017 Dec 15; Vol. 9 (3), pp. 3394-3405. Date of Electronic Publication: 2017 Dec 15 (Print Publication: 2018).

Publication Type: Journal Article

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE